Long-term survival of patients with recurrent endometrial stromal sarcoma: a multicenter, observational study.

ABSTRACT:

Objective

The aim of this study was to evaluate the clinical behavior and management outcome of recurrent endometrial stromal sarcoma (ESS).

Methods

A retrospective review of charts of 10 patients with recurrent ESS was performed and relapse-free interval, relapse site, treatment, response to treatment, duration of follow-up and clinical outcome extracted. Survival outcome measures used were post-relapse survival which was defined as the time from first evidence of relapse to death from any cause. Living patients were censored at the date of last follow-up.

Results

The median age and median relapse-free interval at the time of initial relapse were 51.5 years and 66.5 months, respectively. The number of relapses ranged from one to five. Sixteen surgical procedures for

SUBMITTER: Yamazaki H 

PROVIDER: S-EPMC4510338 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature